KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Shares Repurchased (2017 - 2022)

Pfizer has reported Shares Repurchased over the past 11 years, most recently at $2.0 billion for Q4 2022.

  • Quarterly Shares Repurchased changed N/A to $2.0 billion in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Oct 2023, down 50.0% year-over-year, with the annual reading at $2.0 billion for FY2022, N/A changed from the prior year.
  • Shares Repurchased was $2.0 billion for Q4 2022 at Pfizer, roughly flat from $2.0 billion in the prior quarter.
  • Over five years, Shares Repurchased peaked at $8.9 billion in Q1 2019 and troughed at $1.1 billion in Q3 2018.
  • The 3-year median for Shares Repurchased is $3.5 billion (2018), against an average of $4.2 billion.
  • Year-over-year, Shares Repurchased rose 21.26% in 2018 and then surged 46.21% in 2019.
  • A 3-year view of Shares Repurchased shows it stood at $5.0 billion in 2018, then skyrocketed by 76.24% to $8.9 billion in 2019, then tumbled by 77.44% to $2.0 billion in 2022.
  • Per Business Quant, the three most recent readings for PFE's Shares Repurchased are $2.0 billion (Q4 2022), $2.0 billion (Q2 2022), and $8.9 billion (Q1 2019).